1. Home
  2. RGP vs NYXH Comparison

RGP vs NYXH Comparison

Compare RGP & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

SELL

Current Price

$2.65

Market Cap

93.7M

ML Signal

SELL

Logo Nyxoah SA

NYXH

Nyxoah SA

SELL

Current Price

$0.89

Market Cap

91.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RGP
NYXH
Founded
1996
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.7M
91.6M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
RGP
NYXH
Price
$2.65
$0.89
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
★ $6.50
$2.80
AVG Volume (30 Days)
★ 261.7K
254.5K
Earning Date
01-06-2027
11-05-2026
Dividend Yield
★ 10.41%
N/A
EPS Growth
★ 79.14
N/A
EPS
N/A
★ N/A
Revenue
★ $452,006,000.00
N/A
Revenue This Year
N/A
$234.49
Revenue Next Year
$8.19
$98.07
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.33
$0.80
52 Week High
$5.37
$5.39

Technical Indicators

Market Signals
Indicator
RGP
NYXH
Relative Strength Index (RSI) 38.90 36.80
Support Level $2.58 $0.80
Resistance Level $2.85 $0.97
Average True Range (ATR) 0.10 0.05
MACD 0.04 0.02
Stochastic Oscillator 24.07 68.99

Price Performance

Historical Comparison
RGP
NYXH

About RGP Resources Connection Inc.

Resources Connection Inc is a professional services firm. Its segments include On-Demand Talent provides businesses with a go-to source for bringing in experts when its needed, serving the office of the CFO; Consulting drives transformation across people, processes and technology across domain areas including finance, technology and digital, risk and compliance and operational performance; Europe & Asia Pacific offers both on-demand and consulting services to clients throughout Europe and Asia Pacific; Outsourced Services; and Sitrick. It derives the majority of revenue from On-Demand Talent segment. Geographically, it operates in United States and internationally.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: